AI assistant
SURGICAL INNOVATIONS GROUP PLC — Director's Dealing 2018
Oct 16, 2018
7938_dirs_2018-10-16_bac2570b-5fb8-4d30-a2b8-1867cb3d04d1.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1971E
Surgical Innovations Group PLC
16 October 2018
Surgical Innovations Group plc
(the "Company")
Director/PDMR Shareholding
The Company has been notified that Nigel Rogers, Executive Chairman, today:
(i) acquired 750,000 ordinary shares of 1 penny each in the Company ("Shares") within his ISA, at a price of 2.95p per share; and
(ii) sold 416,830 Shares at a price of 2.95p per share.
Following these transactions, the beneficial holding of Nigel Rogers in the Company is 6,610,000
Shares, representing approximately 0.84% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
For further information please contact:
| Surgical Innovations Group plc Nigel Rogers, Executive Chairman Melanie Ross, COO & CFO WH Ireland Limited (NOMAD & Broker) Tim Feather Walbrook PR (Financial PR & Investor Relations) Paul McManus Lianne Cawthorne |
www.sigroupplc.com |
| Tel: 0113 230 7597 | |
| Tel: 0113 394 6600 | |
| Tel: 020 7933 8780 or [email protected] | |
| Mob: 07980 541893 | |
| Mob: 07584 391303 |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Nigel Rogers | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Executive Chairman, Surgical Innovations Group plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Surgical Innovations Group plc | ||||
| b) | LEI | 2138004GHGUH3HUZE156 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1p GB0004016704 |
||||
| b) | Nature of the transactions | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |||
| 2.95p | 750,000 | |||||
| d) | Aggregated information - Aggregated volume - Price |
750,000 £22,125 |
||||
| e) | Date of the transaction | 16 October 2018 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Nigel Rogers | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Chairman, Surgical Innovations Group plc | |||
| b) | Initial notification/ Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Surgical Innovations Group plc | |||
| b) | LEI | 2138004GHGUH3HUZE156 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1p GB0004016704 |
|||
| b) | Nature of the transactions | Sale of Ordinary Shares | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| 2.95p | 416,830 | ||||
| d) | Aggregated information - Aggregated volume - Price |
416,830 £12,296 |
|||
| e) | Date of the transaction | 16 October 2018 | |||
| f) | Place of the transaction | London Stock Exchange, AIM |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHGCBDGCSBBGIL